AfterRaise/Companies/Pharmacelera

Pharmacelera

Pharmacelera is a company applying Quantum Mechanics and Artificial Intelligence for drug discovery. From its funding announcement.

€6M UndisclosedRaised 8 months agoBarcelona, SpainBiotech & PharmaSpain
Visit website →

In their own words

What Pharmacelera says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "company applying Quantum Mechanics and Artificial Intelligence for drug discovery". Source

Market expansionProductResearch and developmentUS expansion

Public signal Read from the company's own description of what the funding supports.

Why now

Where Pharmacelera is today

Pharmacelera announced a funding round of €6M on 18 February 2026, led by Heran Partners.

Latest round
Undisclosed
Amount
€6M
Announced
18 February 2026
Headquarters
Barcelona, Spain
Sector
Biotech & Pharma
Growth stage
Growth
Investors
Also participating
Clave Capital, Inveready, Bio&Tech Smart Capital
Relevant leadership
CEO Enric Gibert

Momentum AfterRaise intelligence

AfterRaise Score

27
Established
0 funding signals in the last 90 days
Funding recency
9/40
announced within the last year
Round scale
8/25
round size relative to the market
Funding stage
10/20
Undisclosed
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 18 February 2026
    €6M raised
    Led by Heran Partners.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • US market entry
  • New market entry
  • First local hires in the new market
  • Local entity and legal setup

Opportunities this could create

  • Clinical operations
  • Scientific hiring
  • Licensing and BD partnerships
  • Market-entry advisers
  • Local employment infrastructure

Based on the Biotech & Pharma sector, a Growth round and the priorities the company itself set out. Not a statement of fact.

Early momentum5 connected signals
  • 18 February 2026€6M round announced
  • 18 February 2026Stated priority: market expansion
  • 18 February 2026Stated priority: product
  • 18 February 2026Stated priority: research and development
  • 18 February 2026Stated intent: us expansion AfterRaise intelligence

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Pharmacelera is open to

Not yet specified

Pharmacelera has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Pharmacelera

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Pharmacelera?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Biotech & Pharma companies

See the sector